Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants.

Published byRobert Sobczak Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants."— Presentation transcript:

1 FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets throughout the study. An ANCOVA was used to compare treatment groups. Analyses were adjusted for the month 3 observation (before the start of the weight-loss intervention). Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( Am J Clin Nutr, Volume 107, Issue 6, 07 May 2018, Pages 921–931, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 2 Participant disposition throughout the study.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( Am J Clin Nutr, Volume 107, Issue 6, 07 May 2018, Pages 921–931, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 3 Doctors leaving (Matthews, 2013, p.13.)

Figure 3 Doctors leaving (Matthews, 2013, p.13.)
FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.

Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
FIGURE 1 PRISMA flow diagram of studies in systematic review

FIGURE 1 PRISMA flow diagram of studies in systematic review
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...

Similar presentations

Ads by Google